Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587118 · ClinicalTrials.gov registry record · Phase 4
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
A Phase 4 study of Posttraumatic Stress Disorder, sponsored by Lori Davis, MD.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01587118 is a Phase 4 study of Posttraumatic Stress Disorder that has completed, run by Lori Davis, MD. The registered enrollment target is 18 participants, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01587118, a Phase 4 study of Posttraumatic Stress Disorder, has completed, sponsored by Lori Davis, MD.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label pilot study of adjunctive asenapine for the treatment of Posttraumatic Stress Disorder (PTSD) in veterans who have not fully remitted to an adequate trial of standard antidepressant treatment.
Conditions Studied
Interventions
- DRUG Adjunctive asenapine
Study Locations (1)
Alabama
- Tuscaloosa VA Medical Center - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587118
The ClinicalTrials.gov registry entry for NCT01587118 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (84% lower). The listed sponsor is Lori Davis, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Adjunctive asenapine is the first listed.
NCT01587118 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT01587118 about?
NCT01587118 is a clinical study titled "An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder". This is an open-label pilot study of adjunctive asenapine for the treatment of Posttraumatic Stress Disorder (PTSD) in veterans who have not fully remitted to an adequate trial of standard antidepressant treatment.
What is the current status of trial NCT01587118?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2012-06. Estimated completion is 2016-07.
What conditions does trial NCT01587118 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder.
What interventions are being tested in trial NCT01587118?
The interventions under investigation include: Adjunctive asenapine (DRUG).
Who is sponsoring clinical trial NCT01587118?
This trial is sponsored by Lori Davis, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01587118 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
ACTIVE NOT RECRUITING · Phase 4
-
A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol
COMPLETED · Phase 4
-
A Study of Sertraline to Prevent PTSD
COMPLETED · Phase 4
-
Reducing Cannabis Overuse With Prazosin
COMPLETED · Phase 4
-
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
COMPLETED · Phase 4
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.